We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
+3.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$11.3B
AUM Growth
+$388M
(+3.6%)
Cap. Flow
-$337M
Cap. Flow
% of AUM
-2.98%
Top 10 Holdings %
Top 10 Hldgs %
13.82%
Holding
1,006
New
37
Increased
365
Reduced
473
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$30.8M |
| 2 |
UnitedHealth
UNH
|
+$29M |
| 3 |
Simon Property Group
SPG
|
+$25.8M |
| 4 |
Visa
V
|
+$22.9M |
| 5 |
Criteo S.A. Ordinary Shares
CRTO
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$27.1M |
| 2 |
Lowe's Companies
LOW
|
+$21.7M |
| 3 |
VEON
VEON
|
+$20.5M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$20M |
| 5 |
NVIDIA
NVDA
|
+$19.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.2% |
| 2 | Financials | 13.95% |
| 3 | Technology | 13.53% |
| 4 | Consumer Discretionary | 11.82% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Eli Lilly
LLY
$1.02T
| $62.5M | 0.55% |
759,003
-22,027
| -3% | -$1.8M |
|
27
GE Aerospace
GE
$374B
| $62.4M | 0.55% |
482,021
+53,668
| +13% | +$7.36M |
|
28
PepsiCo
PEP
$190B
| $62.1M | 0.55% |
537,935
+10,998
| +2% | +$1.26M |
|
|
RTN
29
DELISTED
Raytheon Company
RTN
| $61.7M | 0.55% |
382,384
+21,649
| +6% | +$3.43M |
|
30
Chevron
CVX
$392B
| $60.8M | 0.54% |
582,966
+27,608
| +5% | +$2.92M |
|
31
Honeywell
HON
$77B
| $60M | 0.53% |
498,391
-103,534
| -17% | -$12.2M |
|
32
Broadcom
AVGO
$1.85T
| $59.3M | 0.52% |
2,544,210
+719,820
| +39% | +$16.7M |
|
33
Johnson & Johnson
JNJ
$618B
| $59.2M | 0.52% |
447,464
-112,979
| -20% | -$14.4M |
|
34
Union Pacific
UNP
$174B
| $57.7M | 0.51% |
529,726
+3,062
| +0.6% | +$334K |
|
|
BERY
35
DELISTED
Berry Global Group, Inc.
BERY
| $56.3M | 0.5% |
1,075,553
+44,338
| +4% | +$2.22M |
|
36
Mastercard
MA
$502B
| $56.3M | 0.5% |
463,163
-127,584
| -22% | -$15.1M |
|
37
Edwards Lifesciences
EW
$49.6B
| $55M | 0.49% |
1,395,837
-396,666
| -22% | -$14.5M |
|
38
Northrop Grumman
NOC
$77.1B
| $54.4M | 0.48% |
212,059
+1,052
| +0.5% | +$263K |
|
39
Walt Disney
DIS
$167B
| $53M | 0.47% |
499,297
+16,270
| +3% | +$1.78M |
|
40
Boston Scientific
BSX
$69.5B
| $52.7M | 0.47% |
1,901,735
-467,063
| -20% | -$12.4M |
|
41
Wells Fargo
WFC
$261B
| $51.9M | 0.46% |
936,521
-13,377
| -1% | -$717K |
|
42
LyondellBasell Industries
LYB
$20B
| $51.8M | 0.46% |
613,405
-6,387
| -1% | -$530K |
|
43
Abbott
ABT
$183B
| $50.9M | 0.45% |
1,046,216
+137,437
| +15% | +$6.22M |
|
44
Sabre
SABR
$731M
| $50.8M | 0.45% |
2,333,054
+311,175
| +15% | +$7.09M |
|
45
Trane Technologies
TT
$100B
| $50.3M | 0.45% |
550,003
+323
| +0.1% | +$28.3K |
|
46
Intercontinental Exchange
ICE
$85.6B
| $49.5M | 0.44% |
750,355
+29,588
| +4% | +$1.81M |
|
47
Alkermes
ALKS
$8.22B
| $49.3M | 0.44% |
850,195
+12,392
| +1% | +$720K |
|
|
SCHW
48
Charles Schwab
SCHW
$183B
| $48.2M | 0.43% |
1,121,444
+372,894
| +50% | +$14.9M |
|
49
Jazz Pharmaceuticals
JAZZ
$15.9B
| $48.1M | 0.43% |
309,268
+33,334
| +12% | +$5.1M |
|
50
Altria Group
MO
$114B
| $45.7M | 0.4% |
613,794
-62,871
| -9% | -$4.6M |
|
Similar funds
BNP Paribas Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, BNP Paribas Asset Management held 1,006 positions worth $11.3B, up 3.6% from $10.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Asset Management's Q2 2017 filing shows 37 new, 365 increased, 473 reduced and 49 closed positions. Its largest new stake was Gramercy Property Trust: 472,258 shares worth $14M. The largest sale was Alibaba, an estimated $27.1M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- BNP Paribas Asset Management's largest Q2 2017 buy was Gramercy Property Trust: 472,258 shares worth $14M.
- BNP Paribas Asset Management added most to Bristol-Myers Squibb in Q2 2017, an estimated $30.8M increase.
- BNP Paribas Asset Management's biggest Q2 2017 reduction was Alibaba, cutting an estimated $27.1M.
- BNP Paribas Asset Management fully exited CyrusOne Inc Common Stock in Q2 2017, selling an estimated $12.1M.
- BNP Paribas Asset Management's ten largest holdings make up 14% of its $11.3B portfolio in Q2 2017.
- BNP Paribas Asset Management opened 37 new positions and closed 49 in Q2 2017.
- BNP Paribas Asset Management's portfolio value rose 3.6% quarter-over-quarter to $11.3B.
Based on BNP Paribas Asset Management's 13F filing for Q2 2017, filed 4 Aug 2017.